Table 3 Responses to question 21 (Do you think RECIST 1.1 criteria should be applied in clinical practice and not only in clinical trials?). Results have been dichotomized according to geographic regions (Europe vs other countries), working experience (< 10 years vs > 10 years), and type of institutions (research facilities—university hospital and research institute vs other institutes). A p-value < 0.05 was considered statistically significant
Never | Yes, always | Yes, but only in specific cases | |
|---|---|---|---|
Total no. of responses | 36/286 (12.6%) | 174/286 (60.8%) | 76/286 (26.6%) |
Europe | 26/197 (13.2%) | 113/197 (57.4%) | 58/197 (29.4%) |
Other countries | 10/89 (11.3%) | 61/89 (68.5%) | 18/89 (20.2%) |
p-value | 0.63 | 0.08 | 0.11 |
Unexperienced | 17/115 (14.8%) | 69/115 (60%) | 29/115 (25.2%) |
Experienced | 19/171 (11.1%) | 105/171 (61.4%) | 47/171 (27.5%) |
p-value | 0.32 | 0.86 | 0.71 |
Research facilities | 25/148 (16.9%) | 82/148 (55.4%) | 41/148 (27.7%) |
Other institutes | 11/138 (8%) | 92/138 (66.7%) | 35/138 (25.3%) |
p-value | 0.02 | 0.04 | 0.57 |